Evidence map›Paper›PMID 29185453›Full record

ArticleScientific reports2017

Dysregulation of YAP by ARF Stimulated with Tea-derived Carbon Nanodots.

Yingqiu Xie, Qinglei Sun, Ayan A Nurkesh, Jiang Lu, Sholpan Kauanova, Jinhong Feng, Darkhan Tursynkhan, Qing Yang, Aishabibi Kassymbek, Mirat Karibayev and 7 more

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
0.9field-weighted citation impact, top 28% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 23 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Review
  5. Review
  6. Review
  7. Article
  8. Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors at 4 institutions in 3 countries.

Yingqiu XieDepartment of Biology, School of Science and Technology, Nazarbayev University, Astana, 010000, Kazakhstan. yingqiu.xie@nu.edu.kz.
Qinglei SunShandong Analysis and Test Center, Shandong Academy of Sciences, 19 Keyuan Street, Jinan, 250014, China.
Ayan A NurkeshDepartment of Biology, School of Science and Technology, Nazarbayev University, Astana, 010000, Kazakhstan.
Jiang LuDepartment of Urology, Shenzhen University Luohu Hospital; Shenzhen Following Precision Medical Research Institute, Luohu Hospital Group, Shenzhen, 51800, China.
Sholpan KauanovaDepartment of Biology, School of Science and Technology, Nazarbayev University, Astana, 010000, Kazakhstan.
Jinhong FengShandong Analysis and Test Center, Shandong Academy of Sciences, 19 Keyuan Street, Jinan, 250014, China.
Darkhan TursynkhanDepartment of Chemistry, School of Science and Technology, Nazarbayev University, Astana, 010000, Kazakhstan.
Qing YangDepartment of Biology, School of Science and Technology, Nazarbayev University, Astana, 010000, Kazakhstan.
Aishabibi KassymbekDepartment of Chemistry, School of Science and Technology, Nazarbayev University, Astana, 010000, Kazakhstan.
Mirat KaribayevDepartment of Chemistry, School of Science and Technology, Nazarbayev University, Astana, 010000, Kazakhstan.
Korlan DuisenovaDepartment of Chemistry, School of Science and Technology, Nazarbayev University, Astana, 010000, Kazakhstan.
Haiyan FanDepartment of Chemistry, School of Science and Technology, Nazarbayev University, Astana, 010000, Kazakhstan. haiyan.fan@nu.edu.kz.ORCID 0000-0002-8537-1825
Xiao WangShandong Analysis and Test Center, Shandong Academy of Sciences, 19 Keyuan Street, Jinan, 250014, China.
Limara ManarbekDepartment of Biology, School of Science and Technology, Nazarbayev University, Astana, 010000, Kazakhstan.
Aisulu MaipasDepartment of Biology, School of Science and Technology, Nazarbayev University, Astana, 010000, Kazakhstan.
Zhenbang ChenDepartment of Biochemistry and Cancer Biology, Meharry Medical College, Nashville, TN, 37208, USA.
Mannix P BalanayDepartment of Chemistry, School of Science and Technology, Nazarbayev University, Astana, 010000, Kazakhstan.
Nazarbayev University · KZShandong Academy of Sciences · CNMeharry Medical College · USShenzhen University · CN

Funding

The RCMI Program in Health Disparities Research at Meharry Medical College - SupplementU54MD007586 · NIMHD · MEHARRY MEDICAL COLLEGE · PI Maureen Sanderson · 2017 to 2026
$48.2M
Translational Pathology CoreU54CA163069 · NCI · MEHARRY MEDICAL COLLEGE · PI ADUNYAH, SAMUEL EVANS · 2011 to 2025
$18.8M
NCI NIH HHS U54 CA163069NIMHD NIH HHS U54 MD007586
6 · The paper itself

Abstract

YAP is a downstream nuclear transcription factor of Hippo pathway which plays an essential role in development, cell growth, organ size and homeostasis. It was previously identified that elevation of YAP in genomics of genetic engineered mouse (GEM) model of prostate cancer is associated with Pten/Trp53 inactivation and ARF elevation hypothesizing the essential crosstalk of AKT/mTOR/YAP with ARF in prostate cancer. However, the detailed function and trafficking of YAP in cancer cells remains unclear. Using GEM microarray model, we found ARF dysregulates Hippo and Wnt pathways. In particular, ARF knockdown reduced non-nuclear localization of YAP which led to an increase in F-actin. Mechanistically, ARF knockdown suppressed protein turnover of β-catenin/YAP, and therefore enhanced the activity of AKT and phosphorylation of YAP. Moreover, we found tea-derived carbon dots can interact with ARF in nucleus that may further lead to the non-nuclear localization of YAP. Thus, we reported a novel crosstalk of ARF/β-catenin dysregulated YAP in Hippo pathway and a new approach to stimulate ARF-mediated signaling to inhibit nuclear YAP using nanomaterials implicating an innovative avenue for treatment of cancer.

Indexed as

Adaptor Proteins, Signal TransducingAnimalsCarbonCell Cycle ProteinsCell NucleusCyclin-Dependent Kinase Inhibitor p19Epithelial-Mesenchymal TransitionHippo Signaling PathwayMaleMiceMicroscopy, ConfocalNanotechnologyPhosphoproteinsProstatic NeoplasmsProtein Serine-Threonine KinasesTeaAdaptor Proteins, Signal TransducingCarbonCell Cycle ProteinsCyclin-Dependent Kinase Inhibitor p19PhosphoproteinsProtein Serine-Threonine KinasesTeaYap1 protein, mouseYAP-Signaling Proteins

Identifiers

PMID29185453
PMCPMC5707370
OpenAlexW2769282880

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.